Effects of long-term use of raloxifene, a selective estrogen receptor modulator, on thyroid function test profiles

Clinical Chemistry

Volumn 47, Issue 10, 2001, Pages 1865-1867

  Hsu, S H J ^a   Cheng, W C ^a   Jang, M W ^a   Tsai, K S ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; LIOTHYRONINE; LIPID; MEDROXYPROGESTERONE ACETATE; PLASMA PROTEIN; PROGESTERONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; THYROTROPIN; THYROXINE; THYROXINE BINDING GLOBULIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; DRUG EFFECT; DRUG USE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; LONG TERM CARE; OSTEOPOROSIS; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; THYROID FUNCTION TEST;

EID: 0034833996     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.10.1865     Document Type: Article

References (16)

1. Free thyroxine and free thyroxine index in women taking oral contraceptives
2. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure
3. Use of direct thyroxine-binding globulin measurement in the evaluation of thyroid function
4. Decrease of free thyroxine levels after controlled ovarian hyperstimulation
5. Role of plasma proteins in binding distribution, and metabolism of the thyroid hormones
6. Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: A mechanism for estrogen-induced elevation of serum TBG concentration
7. Effect of adjuvant tamoxifen therapy on thyroid function in postmenopausal women with breast cancer
8. Thyroid function in postmenopausal women with breast cancer on tamoxifen
9. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
10. A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women
11. Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: Three-year data from 2 double-blind, randomized, placebo-controlled trials
12. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
13. The effect of raloxifene on the risk of breast cancer in postmenopausal women: Results from the MORE randomized trial
14. A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium
15. Effect of bone area on spine density in Chinese men and women in Taiwan
16. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: A randomized, controlled trail